Apellis Pharmaceuticals, Inc. (APLS)

24.56 -0.66 (-2.64%) USD  |  NASDAQ  |  Dec 15, 16:00
24.52 -0.04 (-0.18%) After-Hours: 20:00
More

Apellis Pharmaceuticals Total Expenses (Annual)

Total Expenses (Annual) Chart

View Total Expenses (Annual) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Annual) Range, Past 5 Years

View Total Expenses (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Annual) Benchmarks

View Total Expenses (Annual) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Ultragenyx Pharmaceutical, Inc. Upgrade
Fulcrum Therapeutics, Inc. Upgrade